middle.news
TrivarX Advances Stabl-Im Brain Imaging Toward Phase 1 Trials with New CEO Appointment
10:26am on Thursday 30th of April, 2026 AEST
•
Healthcare
Read Story
TrivarX Advances Stabl-Im Brain Imaging Toward Phase 1 Trials with New CEO Appointment
10:26am on Thursday 30th of April, 2026 AEST
Key Points
Progress toward Phase 1 clinical trials for Stabl-Im
Appointment of Dr Danielle Meyrick as new CEO
Strong cash position of $2.91 million
Enhanced board involvement in commercialisation
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Trivarx (ASX:TRI)
OPEN ARTICLE